Um Microquin

Über das Unternehmen

MicroQuin is a biotechnology company founded by Dr. Scott Robinson of Imperial College London and Yang Zheng of the University of Chicago. Focused on a novel and broadly impactful target, MicroQuin created smarter therapeutics to address the world’s most challenging diseases, with initial focus on cancer. MicroQuin was a 2018 MassChallenge Finalist (premier global accelerator) and winner of the CASIS/Boeing Prize to fund research on the International Space Station. The company is currently headquartered at the prestigious LabCentral in Kendall Square, Cambridge, MA.